Burkehill Global Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
Burkehill Global Management's DNTH Position: Q3 2026 in Review
Burkehill Global Management sold out of Dianthus Therapeutics (DNTH) in Q3 2026, closing a stake of 50,000 shares — an estimated $4.87M sold.
Burkehill Global Management first reported a position in DNTH in Q1 2026 and held it in 2 quarters. The position peaked at $4.87M in Q2 2026. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- Burkehill Global Management reported no remaining Dianthus Therapeutics position as of Q3 2026 after selling out during the quarter.
- Burkehill Global Management sold 50,000 Dianthus Therapeutics shares in Q3 2026, an estimated $4.87M.
- Burkehill Global Management first reported a position in Dianthus Therapeutics in Q1 2026 and held it in 2 quarters.
- Burkehill Global Management's Dianthus Therapeutics position peaked at $4.87M in Q2 2026.
- 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on Burkehill Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.